FDA Calls for Restrictions on Ovarian Cancer Drug Rubraca Due to High Mortality Rates
The FDA is seeking restrictions on the ovarian cancer drug Rubraca, following data indicating it may increase the risk of death in some patients.
November 18, 2022 By: Irvin Jackson
The FDA is seeking restrictions on the ovarian cancer drug Rubraca, following data indicating it may increase the risk of death in some patients.
A federal judge has ordered the CEO of 3M Company to attend settlement negotiations over Combat Arms earplugs hearing loss litigation.
Plaintiffs have filed a Master Complaint in consolidated hair relaxer litigation, which will help make direct filing of cases to the MDL court easier.
A federal judge has ordered parties to sift through Paraquat lawsuits to identify cases which are unlikely to move forward based on patient deaths and implausible theories of proof.